1. Home
  2. CHD vs INSM Comparison

CHD vs INSM Comparison

Compare CHD & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Church & Dwight Company Inc.

CHD

Church & Dwight Company Inc.

SELL

Current Price

$105.05

Market Cap

23.6B

ML Signal

SELL

Logo Insmed Incorporated

INSM

Insmed Incorporated

HOLD

Current Price

$99.77

Market Cap

22.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHD
INSM
Founded
1846
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.6B
22.4B
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
CHD
INSM
Price
$105.05
$99.77
Analyst Decision
Buy
Strong Buy
Analyst Count
21
24
Target Price
$104.79
★ $198.36
AVG Volume (30 Days)
1.2M
★ 2.5M
Earning Date
10-30-2026
10-29-2026
Dividend Yield
★ 1.20%
N/A
EPS Growth
★ 27.43
N/A
EPS
★ 1.76
N/A
Revenue
★ $6,203,200,000.00
N/A
Revenue This Year
$0.61
$196.76
Revenue Next Year
$4.28
$61.53
P/E Ratio
$58.27
★ N/A
Revenue Growth
★ 1.57
N/A
52 Week Low
$81.33
$90.39
52 Week High
$106.04
$212.75

Technical Indicators

Market Signals
Indicator
CHD
INSM
Relative Strength Index (RSI) 78.39 32.27
Support Level $92.23 $97.66
Resistance Level $106.04 $119.54
Average True Range (ATR) 1.46 3.87
MACD 1.10 -1.15
Stochastic Oscillator 96.19 15.26

Price Performance

Historical Comparison
CHD
INSM

About CHD Church & Dwight Company Inc.

Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. The firm also added Touchland and its hand sanitizer business to its fold in fiscal 2025. Even as it expands its product reach, Church & Dwight still derives around 80% of its sales from its home US market.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.

Share on Social Networks: